Gas Plasma Technology Augments Ovalbumin Immunogenicity and OT‐II T Cell Activation Conferring Tumor Protection in Mice

Abstract Reactive oxygen species (ROS/RNS) are produced during inflammation and elicit protein modifications, but the immunological consequences are largely unknown. Gas plasma technology capable of generating an unmatched variety of ROS/RNS is deployed to mimic inflammation and study the significan...

Descrición completa

Detalles Bibliográficos

Principais autores:	Ramona Clemen, Eric Freund, Daniel Mrochen, Lea Miebach, Anke Schmidt, Bernhard H. Rauch, Jan‐Wilm Lackmann, Ulrike Martens, Kristian Wende, Michael Lalk, Mihaela Delcea, Barbara M. Bröker, Sander Bekeschus
Formato:	Artigo
Idioma:	Inglês
Publicado:	Wiley 2021-05-01
Series:	Advanced Science
Assuntos:	kINPen ovalbumin oxPTM ROS vaccines
Acceso en liña:	https://doi.org/10.1002/advs.202003395
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!